FDA.reportPublic FDA data

Complera (emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG) Oral Tablet

RxCUI
1147337
RxNorm name
Complera (emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG) Oral Tablet
Display name
Complera (emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG) Oral Tablet
Full name
Complera (emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
COMPLERAEMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATEGilead Sciences, Inc.d637cfab-f1e8-4eb3-a1b3-f85ca3bec6122025-07-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1147337

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d637cfab-f1e8-4eb3-a1b3-f85ca3bec612COMPLERA 200 MG / 25 MG / 300 MG Oral Tablet [PSN] · emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Complera] [SBD] · Complera (emtricitabine 200 MG / rilpivirine 25 MG (as rilpivirine hydrochloride 27.5 MG) / tenofovir disoproxil fumarate 300 MG (as tenofovir disoproxil 245 MG)) Oral Tablet [SY] · Complera (emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG) Oral Tablet [SY]421These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 201120250716
9176bf31-c889-47bd-861c-f2d3fc37ab8dCOMPLERA 200 MG / 25 MG / 300 MG Oral Tablet [PSN] · emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Complera] [SBD] · Complera (emtricitabine 200 MG / rilpivirine 25 MG (as rilpivirine hydrochloride 27.5 MG) / tenofovir disoproxil fumarate 300 MG (as tenofovir disoproxil 245 MG)) Oral Tablet [SY] · Complera (emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG) Oral Tablet [SY]410These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 201120250716
54c8bec2-d565-489c-8d7c-afd3cdf78df5COMPLERA 200 MG / 25 MG / 300 MG Oral Tablet [PSN] · emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Complera] [SBD] · Complera (emtricitabine 200 MG / rilpivirine 25 MG (as rilpivirine hydrochloride 27.5 MG) / tenofovir disoproxil fumarate 300 MG (as tenofovir disoproxil 245 MG)) Oral Tablet [SY] · Complera (emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG) Oral Tablet [SY]41These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 201120130315